- Global Pharma News & Resources

Vineti and Quick Specialized Healthcare Logistics Partner to Share Industry Expertise That Helps Strengthen Cell and Gene Therapy Supply Chains

Vineti and Quick Specialized Healthcare Logistics Partner to Share Industry Expertise That Helps Strengthen Cell and Gene Therapy Supply Chains A new tip sheet from industry experts at Vineti and Quick provides time-proven best practices from cell and gene therapy veterans to synchronize personalized therapy supply chains and help bring more transformative treatments to more patients

PR Newswire

SAN FRANCISCO and CHICAGO, Nov. 14, 2018

SAN FRANCISCO and CHICAGO, Nov. 14, 2018 /PRNewswire/ -- In the growing field of personalized cell and gene therapies, supporting systems and supply chains need to be taken as seriously as the science. Today, two leaders in cell and gene therapy supply chain solutions—Vineti, Inc and Quick Specialized Healthcare Logistics—have partnered to help biopharma innovators do just that by releasing a new tip sheet focused on industry-proven best practices.

Covering everything from cell and gene therapy's (CGT) need for continuous collaboration to appropriate packaging and transportation routing strategies, Cell and Gene Therapies: Eight Tips to Strengthen Your Supply Chain from Vineti and Quick offers valuable advice from industry veterans who were among the first to provide operations, logistics, and supply chain support for personalized medicine therapies. Together, the authors of the tip sheet have more than 35 years of combined industry experience that can help support this rapidly developing field.

"Vineti's expert team is asked to advise the cell and gene therapy industry every day, and we're always happy to help," said Amy DuRoss, CEO and co-founder of Vineti. "The deeply experienced team at Quick has also done pioneering work in cell and gene therapy, and we know from our shared integrations that Quick's leadership helps keep the industry moving. We've very pleased to have this chance to partner with Quick to share some of our collective knowledge."

"Quick is honored to serve the biopharma industry and provide logistics support for these promising personalized medicine therapies," said David Murphy, Executive VP of Quick Life Sciences.  "The CGT supply chain is complex and requires sophisticated technology platforms to synchronize the entire process.  We are excited to be partnering with Vineti, digital innovation experts, and offer a proven solution that automates, integrates, and tracks the entire supply chain, helping to ensure patient success."

Vineti and Quick work together in a variety of ways to offer robust integrated logistics and supply chain solutions to biopharmaceutical partners. Both companies have significant experience supporting both clinical and commercial-phase therapies, and the Quick-Vineti integration can help therapies scale at any phase.

Quick's end-to-end logistics solution provides around-the-clock support to meet the unique logistics and shipping needs of cell and gene therapies. Quick has been supporting the unique needs of the healthcare industry for over 35 years, delivering customized solutions that save lives and providing industry-leading cold chain logistics and strict chain of custody protocols to ensure the integrity of each shipment. Vineti provides the leading digital "platform of record" for next-generation therapies that aligns, tracks, and documents the entire cell therapy process, from ordering and logistics to manufacturing and clinical data. When combined, the resulting Quick-Vineti partnership is actively working together daily to create a strong, scalable supply chain for leading cell and gene therapies.

"Cell and Gene Therapies: Eight Tips to Strengthen Your Supply Chain" is available from Vineti at and from Quick at . The Vineti-Quick supply chain solution is offered to all of Quick's clients throughout the world, as well as directly through Vineti's business development team. 

About Vineti, Inc.
Vineti is the first commercial, configurable, cloud-based software platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies. The Vineti "platform of record" integrates logistics, manufacturing and clinical data for individualized therapies to align and orchestrate the cell and gene therapy process and improve product performance overall. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there's an opportunity to provide greater health outcomes—and cures—to patients in need. The company is growing rapidly, and the Vineti platform is now in use world-wide. For more information, please visit Sign up to follow @vinetiworks on

About Quick Specialized Healthcare Logistics
For over 35 years, The Quick Group has been serving the global life science and healthcare community, providing 24/7 customized logistics and transportation solutions for time-and temperature-sensitive, mission-critical and life-saving needs.  As the trusted logistics leader, Quick safely and quickly transports personalized medicine, human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices and equipment, operating from our CGT Center of Excellence locations in Chicago and London.

For more information, please visit

NOTE: Vineti and the Vineti logo are trademarks of Vineti, Inc.  Quick and the Quick logo are trademarks of The Quick Group. All other trademarks and service marks are the property of their respective owners.

Media Contacts:

Kaustuva Das
Thermal PR for Vineti

Marie T. Vigliarolo,
SVP Marketing for The Quick Group
718-995-3616 ext. 2207



View original content to download multimedia:

SOURCE Vineti, Inc.; Quick Specialized Healthcare Logistics

Editor Details

Last Updated: 14-Nov-2018